{"id":"NCT01382602","sponsor":"Cook MyoSite","briefTitle":"Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study","officialTitle":"A Double-blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Effectiveness of Cook MyoSite Incorporated AMDC in Female Patients With Stress Urinary Incontinence","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11-04","primaryCompletion":"2016-02-03","completion":"2017-01-29","firstPosted":"2011-06-27","resultsPosted":"2018-05-17","lastUpdate":"2018-05-17"},"enrollment":150,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Incontinence, Stress"],"interventions":[{"type":"BIOLOGICAL","name":"AMDC-USR","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"AMDC-USR","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a clinical trial to study the safety and effectiveness of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) for the treatment of female stress urinary incontinence (SUI).","primaryOutcome":{"measure":"Percentage of Participants With Response (Based on Stress IEF, or In-office Pad Weight Test, or 24-hour Pad Weight Test) at 12 Months","timeFrame":"12 months","effectByArm":[{"arm":"AMDC-USR","deltaMin":82,"sd":null},{"arm":"Placebo","deltaMin":90,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":10},"locations":{"siteCount":10,"countries":["Canada","Germany","United Kingdom"]},"refs":{"pmids":["30178605"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":93},"commonTop":["Urinary tract infection","Dysuria","Nausea","Pollakiuria","Injection site pain"]}}